Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Dec;78(12):917–920. doi: 10.1136/bjo.78.12.917

Effect of interleukin 1 receptor antagonist on the blood-aqueous barrier after intraocular lens implantation.

O Nishi 1, K Nishi 1, Y Ohmoto 1
PMCID: PMC504993  PMID: 7819176

Abstract

Interleukin 1 (IL-1) possesses as an intercellular signal a wide spectrum of inflammatory, metabolic, haematopoetic, immunological, and reparative properties and can be a mediator not only of host defence but also of disease. Reduction of IL-1 can decrease the inflammatory host response. A human recombinant IL-1 receptor antagonist (IL-1ra) was used to block IL-1 after intraocular lens implantation in rabbits. Seventeen rabbits underwent intercapsular phacoemulsification and posterior chamber lens implantation. A 100 micrograms dose (0.1 ml) of IL-1ra (1 mg/ml) was injected into the anterior chamber at the end of surgery in seven rabbits. The 10 rabbits serving as the controls received no IL-1ra. Postoperatively, all rabbits were observed with a slit-lamp, and the aqueous flare intensity was measured with a laser flare cell meter at 12 hours, 1, 2, 3, and 4 days and thereafter at 1, 2, 3, and 4 weeks. Aqueous flare intensity was significantly lower on days 2 and 3, and fibrin deposition much less marked in the eyes treated with IL-1ra, compared with the controls. The results suggest that IL-1 is involved in the postoperative inflammation that occurs after intraocular lens implantation and the use of the IL-1ra would be valuable for reducing this problem.

Full text

PDF
917

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu el Asrar A. M., Maimone D., Morse P. H., Gregory S., Reder A. T. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol. 1992 Dec 15;114(6):731–736. doi: 10.1016/s0002-9394(14)74052-8. [DOI] [PubMed] [Google Scholar]
  2. Arend W. P. Interleukin-1 receptor antagonist. Adv Immunol. 1993;54:167–227. doi: 10.1016/s0065-2776(08)60535-0. [DOI] [PubMed] [Google Scholar]
  3. Bhattacherjee P., Henderson B. Inflammatory responses to intraocularly injected interleukin 1. Curr Eye Res. 1987 Jul;6(7):929–934. doi: 10.3109/02713688709034861. [DOI] [PubMed] [Google Scholar]
  4. Chang J., Gilman S. C., Lewis A. J. Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: a possible signal for IL 1 action. J Immunol. 1986 Feb 15;136(4):1283–1287. [PubMed] [Google Scholar]
  5. Coceani F., Lees J., Redford J., Bishai I. Interleukin-1 receptor antagonist: effectiveness against interleukin-1 fever. Can J Physiol Pharmacol. 1992 Dec;70(12):1590–1596. doi: 10.1139/y92-228. [DOI] [PubMed] [Google Scholar]
  6. Conti P., Barbacane R. C., Felaco M., Grilli A., Placido F. C., Reale M. Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2 (PGE2) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4. Immunol Lett. 1993 Jul;37(1):1–6. doi: 10.1016/0165-2478(93)90124-k. [DOI] [PubMed] [Google Scholar]
  7. Dinarello C. A., Ikejima T., Warner S. J., Orencole S. F., Lonnemann G., Cannon J. G., Libby P. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol. 1987 Sep 15;139(6):1902–1910. [PubMed] [Google Scholar]
  8. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  9. Farrar W. L., Humes J. L. The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J Immunol. 1985 Aug;135(2):1153–1159. [PubMed] [Google Scholar]
  10. Guise T. A., Garrett I. R., Bonewald L. F., Mundy G. R. Interleukin-1 receptor antagonist inhibits the hypercalcemia mediated by interleukin-1. J Bone Miner Res. 1993 May;8(5):583–587. doi: 10.1002/jbmr.5650080509. [DOI] [PubMed] [Google Scholar]
  11. Hannum C. H., Wilcox C. J., Arend W. P., Joslin F. G., Dripps D. J., Heimdal P. L., Armes L. G., Sommer A., Eisenberg S. P., Thompson R. C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990 Jan 25;343(6256):336–340. doi: 10.1038/343336a0. [DOI] [PubMed] [Google Scholar]
  12. Kulkarni P. S., Mancino M. Studies on intraocular inflammation produced by intravitreal human interleukins in rabbits. Exp Eye Res. 1993 Mar;56(3):275–279. doi: 10.1006/exer.1993.1036. [DOI] [PubMed] [Google Scholar]
  13. Lundgren B., Ocklind A., Holst A., Härfstrand A. Inflammatory response in the rabbit eye after intraocular implantation with poly(methyl methacrylate) and heparin surface modified intraocular lenses. J Cataract Refract Surg. 1992 Jan;18(1):65–70. doi: 10.1016/s0886-3350(13)80385-9. [DOI] [PubMed] [Google Scholar]
  14. Malecaze F., Chollet P., Cavrois E., Vita N., Arné J. L., Ferrara P. Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol. 1991 Dec;109(12):1681–1683. doi: 10.1001/archopht.1991.01080120065027. [DOI] [PubMed] [Google Scholar]
  15. May L. T., Torcia G., Cozzolino F., Ray A., Tatter S. B., Santhanam U., Sehgal P. B., Stern D. Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun. 1989 Mar 31;159(3):991–998. doi: 10.1016/0006-291x(89)92206-7. [DOI] [PubMed] [Google Scholar]
  16. Meyers K. P., Czachowski C. L., Coffey J. W. Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat. Inflammation. 1993 Apr;17(2):121–134. doi: 10.1007/BF00916099. [DOI] [PubMed] [Google Scholar]
  17. Miyake K., Mibu H., Horiguchi M., Shirasawa E. Inflammatory mediators in postoperative aphakic and pseudophakic baboon eyes. Arch Ophthalmol. 1990 Dec;108(12):1764–1767. doi: 10.1001/archopht.1990.01070140118041. [DOI] [PubMed] [Google Scholar]
  18. Nishi O., Nishi K. Disruption of the blood-aqueous barrier by residual lens epithelial cells after intraocular lens implantation. Ophthalmic Surg. 1992 May;23(5):325–329. [PubMed] [Google Scholar]
  19. Nishi O., Nishi K., Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol. 1992 Jun;76(6):338–341. doi: 10.1136/bjo.76.6.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990 Dec 6;348(6301):550–552. doi: 10.1038/348550a0. [DOI] [PubMed] [Google Scholar]
  21. Planck S. R., Dang T. T., Graves D., Tara D., Ansel J. C., Rosenbaum J. T. Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci. 1992 Jan;33(1):78–82. [PubMed] [Google Scholar]
  22. Planck S. R., Huang X. N., Robertson J. E., Rosenbaum J. T. Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr Eye Res. 1993 Mar;12(3):205–212. doi: 10.3109/02713689308999465. [DOI] [PubMed] [Google Scholar]
  23. Roberge F. G., Caspi R. R., Nussenblatt R. B. Glial retinal Müller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity. J Immunol. 1988 Apr 1;140(7):2193–2196. [PubMed] [Google Scholar]
  24. Rosenbaum J. T., Boney R. S. Activity of an interleukin 1 receptor antagonist in rabbit models of uveitis. Arch Ophthalmol. 1992 Apr;110(4):547–549. doi: 10.1001/archopht.1992.01080160125049. [DOI] [PubMed] [Google Scholar]
  25. Rosenbaum J. T., Samples J. R., Hefeneider S. H., Howes E. L., Jr Ocular inflammatory effects of intravitreal interleukin 1. Arch Ophthalmol. 1987 Aug;105(8):1117–1120. doi: 10.1001/archopht.1987.01060080119040. [DOI] [PubMed] [Google Scholar]
  26. Seckinger P., Klein-Nulend J., Alander C., Thompson R. C., Dayer J. M., Raisz L. G. Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J Immunol. 1990 Dec 15;145(12):4181–4184. [PubMed] [Google Scholar]
  27. Shams N. B., Reddy C. V., Watanabe K., Elgebaly S. A., Hanninen L. A., Kenyon K. R. Increased interleukin-1 activity in the injured vitamin A-deficient cornea. Cornea. 1994 Mar;13(2):156–166. doi: 10.1097/00003226-199403000-00009. [DOI] [PubMed] [Google Scholar]
  28. Tilden M. E., Boney R. S., Goldenberg M. M., Rosenbaum J. T. The effects of topical S(+)-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model. J Ocul Pharmacol. 1990 Summer;6(2):131–135. doi: 10.1089/jop.1990.6.131. [DOI] [PubMed] [Google Scholar]
  29. Yokoyama T. [Interleukin-1 beta in the aqueous humor in aphakic and pseudophakic eyes of rabbits]. Nippon Ganka Gakkai Zasshi. 1992 Jan;96(1):67–73. [PubMed] [Google Scholar]
  30. di Giovine F. S., Duff G. W. Interleukin 1: the first interleukin. Immunol Today. 1990 Jan;11(1):13–20. doi: 10.1016/0167-5699(90)90005-t. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES